Bretylium and Dobutamine in the Treatment of Coronary Artery Disease

Overview

Journal Bull N Y Acad Med

Specialty General Medicine

Date 1979 Sep 1

PMID 290401

Authors

W H Frishman

Affiliations

Soon will be listed here.

References

Sakamoto T, Yamada T . Hemodynamic effects of dobutamine in patients following open heart surgery. Circulation. 1977; 55(3):525-33. DOI: 10.1161/01.cir.55.3.525. View

Murphy P, Williams T, Kau D . Disposition of dobutamine in the dog. J Pharmacol Exp Ther. 1976; 199(2):423-31. View

Lumley P, Broadley K, Levy G . Analysis of the inotropic: chronotropic selectivity of dobutamine and dopamine in anaethetised dogs and guinea-pig isolated atria. Cardiovasc Res. 1977; 11(1):17-25. DOI: 10.1093/cvr/11.1.17. View

Loeb H, Bredakis J, Gunner R . Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure. Circulation. 1977; 55(2):375-8. DOI: 10.1161/01.cir.55.2.375. View

Leier C, Heban P, Huss P, Bush C, Lewis R . Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation. 1978; 58(3 Pt 1):466-75. DOI: 10.1161/01.cir.58.3.466. View

Kirk E, Lejemtel T, Nelson G, SONNENBLICK E . Mechanisms of beneficial effects of vasodilators and inotropic stimulation in the experimental failing ischemic heart. Am J Med. 1978; 65(1):189-96. DOI: 10.1016/0002-9343(78)90709-x. View

Leier C, Webel J, Bush C . The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation. 1977; 56(3):468-72. DOI: 10.1161/01.cir.56.3.468. View

Gillespie T, Ambos H, Sobel B, Roberts R . Effects of dobutamine in patients with acute myocardial infarction. Am J Cardiol. 1977; 39(4):588-94. DOI: 10.1016/s0002-9149(77)80170-7. View

Holder D, Sniderman A, Fraser G, Fallen E . Experience with bretylium tosylate by a hospital cardiac arrest team. Circulation. 1977; 55(3):541-4. DOI: 10.1161/01.cir.55.3.541. View

10.

Cohen H, Gozo Jr E, LANGENDORF R, Kaplan B, Chan A, Pick A . Response of resistant ventricular tachycardia to bretylium. Relation to site of ectopic focus and location of myocardial disease. Circulation. 1973; 47(2):331-40. DOI: 10.1161/01.cir.47.2.331. View

11.

Jewitt D, Birkhead J, Mitchell A, Dollery C . Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine. Lancet. 1974; 2(7877):363-7. DOI: 10.1016/s0140-6736(74)91754-1. View

12.

Bernstein J, Koch-Weser J . Effectiveness of bretylium tosylate against refractory ventricular arrhythmias. Circulation. 1972; 45(5):1024-34. DOI: 10.1161/01.cir.45.5.1024. View

13.

Tuttle R, Mills J . Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975; 36(1):185-96. DOI: 10.1161/01.res.36.1.185. View

14.

Tuttle R, Hillmann C, TOOMEY R . Differential beta adrenergic sensitivity of atrial and ventricular tissue assessed by chronotropic, inotropic, and cyclic AMP responses to isoprenaline and dobutamine. Cardiovasc Res. 1976; 10(4):452-8. DOI: 10.1093/cvr/10.4.452. View

15.

Alderman E, Kerber R, Harrison D . Evaluation of lidocaine resistance in man using intermittent large-dose infusion techniques. Am J Cardiol. 1974; 34(3):342-9. DOI: 10.1016/0002-9149(74)90037-x. View

16.

Sanna G, Arcidiacono R . Chemical ventricular defibrillation of the human heart with bretylium tosylate. Am J Cardiol. 1973; 32(7):982-7. DOI: 10.1016/s0002-9149(73)80168-7. View

17.

Tinker J, Tarhan S, White R, Pluth J, Barnhorst D . Dobutamine for inotropic support during emergence from cardiopulmonary bypass. Anesthesiology. 1976; 44(4):281-6. DOI: 10.1097/00000542-197604000-00001. View

18.

BEREGOVICH J, Bianchi C, DAngelo R, Diaz R, RUBLER S . Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure. Br Heart J. 1975; 37(6):629-34. PMC: 482847. DOI: 10.1136/hrt.37.6.629. View

19.

Akhtar N, Mikulic E, Cohn J, Chaudhry M . Hemodynamic effect of dobutamine in patients with severe heart failure. Am J Cardiol. 1975; 36(2):202-5. DOI: 10.1016/0002-9149(75)90526-3. View

20.

Luomanmaaki K, Heikkila J, Hartel G . Bretylium Tosylate; adverse effects in acute myocardial infarction. Arch Intern Med. 1975; 135(4):515-8. View